Clinical trial
A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Assess Safety and Effectiveness of Liposom in Enhance and Speed up Response With Citalopram in Elderly Patients Suffering From Major Depressive Disorder (MDD)
NCT04975724 is registered in ClinicalTrials.gov with Fidia Farmaceutici s.p.a. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Assess Safety and Effectiveness of Liposom in Enhance and Speed up Response With Citalopram in Elderly Patients Suffering From Major Depressive Disorder (MDD)
- Lead sponsor
- Fidia Farmaceutici s.p.a.
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 18, 2019
- Completion date
- December 31, 2025
- Enrollment
- 150 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.